Burroughs Amy L.
Chief Executive Officer
Burroughs Amy L. has filed 5 SEC Form 4 filings (17 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: May 5, 2026.
On the most recent filing, Burroughs Amy L. is listed as Chief Executive Officer at Terns Pharmaceuticals, Inc. Inside the rolling window, Burroughs Amy L. reported no open-market purchases and 4 open-market sales totaling $6.5M in TERN. The largest disclosed transaction in the window is a sale of 71,339 TERN shares on Jan 5, 2026, worth $2.7M.
Companies traded
Other insiders at TERN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Burroughs Amy L. made?
Burroughs Amy L. has filed 5 SEC Form 4 filings (17 transaction rows) across 1 company since 2026.
Which companies does Burroughs Amy L. trade?
Burroughs Amy L. has filed SEC Form 4 disclosures for 1 company, including TERN.
When was Burroughs Amy L.'s most recent SEC Form 4 filing?
Burroughs Amy L.'s most recent SEC Form 4 filing on Tracefour is dated May 5, 2026.
What is Burroughs Amy L.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Burroughs Amy L. is listed as Chief Executive Officer.
What is Burroughs Amy L.'s total buy and sell value in the current window?
Inside the rolling retention window, Burroughs Amy L. bought $0 and sold $6.5M based on SEC Form 4 filings.
What was Burroughs Amy L.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 71,339 TERN shares on 2026-01-05, worth $2.7M, per SEC Form 4 filings.